Charlson Co-Morbidity Index as a Predictor of Outcome After Surgery for Renal Cell Carcinoma With Renal Vein, Vena Cava or Right Atrium Extension.
- 1 April 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 169 (4) , 1282-1286
- https://doi.org/10.1097/01.ju.0000049093.03392.cc
Abstract
Purpose: Surgery is the most effective treatment for renal cell carcinoma with tumor thrombus but predictors of outcome and patient survival are variable. Co-morbidity may affect therapeuti...Keywords
This publication has 20 references indexed in Scilit:
- Measuring comorbidity in older cancer patientsEuropean Journal Of Cancer, 2000
- Validation of the Charlson Comorbidity Index in Patients With Head and Neck Cancer: A Multi‐institutional StudyThe Laryngoscope, 1997
- TNM staging of renal cell carcinomaCancer, 1997
- Surgical Management of Renal Cell Carcinoma With Inferior Vena Cava Tumor ThrombusThe Annals of Thoracic Surgery, 1997
- Renal cell carcinoma extending to the renal vein and inferior vena cava: Results of surgical treatment and prognostic factorsJournal of Surgical Oncology, 1995
- Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval, and atrial extensionThe American Journal of Surgery, 1994
- Surgical Management and Prognosis of Renal Cell carcinoma Invading the Vena CavaJournal of Urology, 1991
- Surgical Treatment of Renal Cancer with Vena Cava ExtensionBritish Journal of Urology, 1987
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Extension of Renal Cell Carcinoma into the Vena Cava: The Rationale for Aggressive Surgical ManagementJournal of Urology, 1972